Editas Medicine (EDIT)
(Delayed Data from NSDQ)
$5.32 USD
-0.24 (-4.32%)
Updated May 10, 2024 04:00 PM ET
After-Market: $5.42 +0.10 (1.88%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/7/24 |
---|---|
Current Quarter | -0.68 |
EPS Last Quarter | -0.76 |
Last EPS Surprise | -20.63% |
ABR | 2.06 |
Earnings ESP
|
-5.31% |
---|---|
Current Year | -2.59 |
Next Year | -2.66 |
EPS (TTM) | -2.10 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 6.45M | 10.01M | 33.78M | 26.58M |
# of Estimates | 6 | 7 | 9 | 7 |
High Estimate | 14.70M | 27.50M | 58.70M | 31.67M |
Low Estimate | 2.00M | 2.00M | 1.10M | 20.00M |
Year ago Sales | 2.89M | 5.34M | 78.12M | 33.78M |
Year over Year Growth Est. | 123.32% | 87.47% | -56.77% | -21.29% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.68 | -0.63 | -2.59 | -2.66 |
# of Estimates | 10 | 8 | 12 | 10 |
Most Recent Consensus | -0.57 | -0.53 | -2.08 | -3.04 |
High Estimate | -0.46 | -0.25 | -1.84 | -1.72 |
Low Estimate | -0.84 | -0.81 | -3.37 | -3.46 |
Year ago EPS | -0.56 | -0.55 | -2.02 | -2.59 |
Year over Year Growth Est. | -21.43% | -14.55% | -28.22% | -2.35% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 2 | 3 | 4 |
Up Last 30 Days | 1 | 2 | 3 | 5 |
Up Last 60 Days | 1 | 3 | 3 | 6 |
Down Last 7 Days | 3 | 2 | 3 | 2 |
Down Last 30 Days | 3 | 2 | 3 | 2 |
Down Last 60 Days | 3 | 2 | 4 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.68 | -0.63 | -2.59 | -2.66 |
7 Days Ago | -0.62 | -0.64 | -2.60 | -2.69 |
30 Days Ago | -0.62 | -0.64 | -2.60 | -2.69 |
60 Days Ago | -0.62 | -0.64 | -2.60 | -2.72 |
90 Days Ago | -0.62 | -0.65 | -2.48 | -2.75 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.72 | -0.63 | -2.74 | -2.89 |
Zacks Consensus Estimate | -0.68 | -0.63 | -2.59 | -2.66 |
Earnings ESP | -5.31% | -1.44% | -5.62% | -8.85% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.76 | -0.23 | -0.55 | -0.56 | NA |
Estimate | -0.63 | -0.52 | -0.64 | -0.76 | NA |
Difference | -0.13 | 0.29 | 0.09 | 0.20 | 0.11 |
Surprise | -20.63% | 55.77% | 14.06% | 26.32% | 18.88% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more